Lymphotoxin-α3 mediates monocyte-endothelial interaction by TNFR I/NF-κB signaling

Biochemical and Biophysical Research Communications

Volumn 379, Issue 2, 2009, Pages 374-378

  Suna, Shinichiro ^a   Sakata, Yasuhiko ^a   Shimizu, Masahiko ^a   Nakatani, Daisaku ^a   Usami, Masaya ^a   Matsumoto, Sen ^a   Mizuno, Hiroya ^a   Ozaki, Kouichi ^b   Takashima, Seiji ^a   Takeda, Hiroshi ^a   Tanaka, Toshihiro ^b   Hori, Masatsugu ^c   Sato, Hiroshi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b RIKEN   (Japan)

^c OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Atherosclerosis; Cell adhesion molecule; Lymphotoxin ; NF B; TNF receptor

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOTOXIN; LYMPHOTOXIN ALPHA 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; 2 MORPHOLINO 8 PHENYLCHROMONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; ANDROSTANE DERIVATIVE; CHROMONE DERIVATIVE; MORPHOLINE DERIVATIVE; PROTEIN KINASE INHIBITOR; VASCULAR CELL ADHESION MOLECULE 1; WORTMANNIN;

ARTICLE; ATHEROGENESIS; CELL ADHESION; CELL INTERACTION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIUM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; BIOSYNTHESIS; CELL COMMUNICATION; CELL CULTURE; DRUG ANTAGONISM; GENETICS; METABOLISM; PHYSIOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; CELL ADHESION; CELL COMMUNICATION; CELLS, CULTURED; CHROMONES; CORONARY DISEASE; ENDOTHELIAL CELLS; HUMANS; LYMPHOTOXIN-ALPHA; MONOCYTES; MORPHOLINES; NF-KAPPA B; PROTEIN KINASE INHIBITORS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; VASCULAR CELL ADHESION MOLECULE-1;

EID: 58149496082     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.12.064     Document Type: Article

References (13)

1. Gray P.W., Aggarwal B.B., Benton C.V., Bringman T.S., Henzel W.J., Jarrett J.A., Leung D.W., Moffat B., Ng P., Svedersky L.P., et al. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity. Nature 312 (1984) 721-724
2. Ozaki K., Ohnishi Y., Iida A., Sekine A., Yamada R., Tsunoda T., Sato H., Sato H., Hori M., Nakamura Y., and Tanaka T. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat. Genet. 32 (2002) 650-654
3. Ozaki K., Inoue K., Sato H., Iida A., Ohnishi Y., Sekine A., Sato H., Odashiro K., Nobuyoshi M., Hori M., Nakamura Y., and Tanaka T. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature 429 (2004) 72-75
4. Schreyer S.A., Vick C.M., and LeBoeuf R.C. Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice. J. Biol. Chem. 277 (2002) 12364-12368
5. Mizuno H., Sato H., Sakata Y., Ohnishi Y., Hishida E., Kinjo K., Nakatani D., Shimizu M., Kondo H., Tanaka T., Ozaki K., Hirayama A., Ito H., Otsu K., and Hori M. Impact of atherosclerosis-related gene polymorphisms on mortality and recurrent events after myocardial infarction. Atherosclerosis 185 (2006) 400-405
6. Clarke R., Xu P., Bennett D., Lewington S., Zondervan K., Parish S., Palmer A., Clark S., Cardon L., Peto R., Lathrop M., and Collins R. Lymphotoxin-alpha gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study. PLoS Genet. 2 (2006) e107
7. Iwanaga Y., Ono K., Takagi S., Terashima M., Tsutsumi Y., Mannami T., Yasui N., Goto Y., Nonogi H., and Iwai N. Association analysis between polymorphisms of the lymphotoxin-alpha gene and myocardial infarction in a Japanese population. Atherosclerosis 172 (2004) 197-198
8. Cuff C.A., Schwartz J., Bergman C.M., Russell K.S., Bender J.R., and Ruddle N.H. Lymphotoxin alpha3 induces chemokines and adhesion molecules: insight into the role of LT alpha in inflammation and lymphoid organ development. J. Immunol. 161 (1998) 6853-6860
9. Suna S., Sakata Y., Sato H., Mizuno H., Nakatani D., Shimizu M., Usami M., Takashima S., Takeda H., and Hori M. Up-regulation of cell adhesion molecule genes in human endothelial cells stimulated by lymphotoxin alpha: DNA microarray analysis. J. Atheroscler. Thromb. 15 (2008) 160-165
10. Neumann B., Machleidt T., Lifka A., Pfeffer K., Vestweber D., Mak T.W., Holzmann B., and Kronke M. Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J. Immunol. 156 (1996) 1587-1593
11. Cuff C.A., Sacca R., and Ruddle N.H. Differential induction of adhesion molecule and chemokine expression by LTalpha3 and LTalphabeta in inflammation elucidates potential mechanisms of mesenteric and peripheral lymph node development. J. Immunol. 162 (1999) 5965-5972
12. Hochman P.S., Majeau G.R., Mackay F., and Browning J.L. Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands. J. Inflamm. 46 (1995) 220-234
13. Madge L.A., Kluger M.S., Orange J.S., and May M.J. Lymphotoxin-{alpha}1{beta}2 and LIGHT induce classical and noncanonical NF-{kappa}B-dependent proinflammatory gene expression in vascular endothelial cells. J. Immunol. 180 (2008) 3467-3477